| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Clearside Biomedical, Inc. (CLSDQ) has 0 insiders with recent SEC Form 4 filings, including 9 buys and 2 sells. CLSDQ is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2020 | Humphries William D. | Director | Buy | 5,586 | $1.78 | $9,943.08 | New | |
| Aug 13, 2020 | Whitmore Bradford T75 | 10% Owner | Buy | 350,000 | $1.63 | $571,680.00 | +6.4% | |
| Jun 1, 2020 | Deignan Charles A.69 | Chief Financial Officer | Sell | 14,992 | $1.88 | $28,184.96 | -6.4% | |
| May 20, 2020 | Hutson Nancy J58 | Director | Buy | 5,000 | $1.85 | $9,250.00 | New | |
| May 12, 2020 | Lasezkay George M71 | CEO | Sell | 32,150 | $1.99 | $63,978.50 | -9.4% | |
| Nov 12, 2019 | Deignan Charles A.69 | Chief Financial Officer | Buy | 7,500 | $1.14 | $8,550.00 | +3.8% | |
| Nov 11, 2019 | Lasezkay George M71 | CEO | Buy | 12,000 | $1.16 | $13,920.00 | +5.7% | |
| Mar 15, 2019 | Deignan Charles A.69 | Chief Financial Officer | Buy | 10,000 | $1.36 | $13,600.00 | +15.1% | |
| Dec 6, 2018 | Thorp Clay62 | Director, 10% Owner | Buy | 8,000 | $1.36 | $10,880.00 | New | |
| Jun 4, 2018 | White Daniel H. | President And CEO | Buy | 11,000 | $9.07 | $99,770.00 | +2.3% |